In 2022, Kevin Quinn from Liverpool joined a uMed supported study of patients with chronic respiratory conditions. The study evaluated the effectiveness of a respiratory monitor that measures CO2 levels in tidal breathing of participants. The aim of the research was to help advance the development of point-of-care diagnostic technologies that monitor and manage cardiorespiratory conditions, which have the potential to transform the way we diagnose and treat patients.
We caught up with Kevin upon completion of the study to find out more about his reasons for taking part and to hear about his experiences of participating in this research with uMed. Find out what he had to say…
Why did you choose to join this study?
I had been suffering from a lung condition for some time, so when I received the message about this study from my GP, I was keen to get involved and support any research that had the potential to improve knowledge and understanding of respiratory conditions, and that might bring some relief to others in the future.
How would you describe your experience of taking part in this study?
The whole process went smoothly, uMed handled everything so I was able to participate entirely from home and didn’t have to travel!
I was called by uMed’s Lead Research Nurse, Hannah, who was extremely helpful and professional in talking me through the study and ensuring I was happy to proceed.
I then received a study questionnaire and the respiratory device via post, and the uMed team walked me through how to use the device and how to record my daily symptoms. They also arranged for return of the devices once the study had finished.
I only have praise for the uMed team, their support was 10 out of 10! In particular Hannah was extremely helpful, friendly and professional, and was available to answer any questions I had about the study. This made me, and my wife, feel completely at ease with taking part.
What message do you have for others about participating in research?
Participating in research is so important. As individuals we own all this important information about our health that if shared could have a great impact on the lives of others in the future. How else can new treatments be developed if we don’t share this information?
Want to find out more about this study?
Find out how uMed supported the successful enrolment of 740 patients in to this study, whilst also handling device distribution, device training, and the collection and aggregation of key data to demonstrate efficacy of the device. Read the full case study here.